{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T07:42:25Z","timestamp":1767339745445,"version":"3.48.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004335","name":"Southwest University of Science and Technology","doi-asserted-by":"publisher","award":["2020LZXNYDZ02"],"award-info":[{"award-number":["2020LZXNYDZ02"]}],"id":[{"id":"10.13039\/501100004335","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2022YFS0626"],"award-info":[{"award-number":["2022YFS0626"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.arteri.2025.500800","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T16:03:52Z","timestamp":1744128232000},"page":"500800","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the link between fibrates therapy and diabetes mellitus following primary acute pancreatitis with hypertriglyceridemia"],"prefix":"10.1016","volume":"38","author":[{"given":"Jiali","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nana","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhouyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingming","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arteri.2025.500800_bib0155","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S2468-1253(16)30004-8","article-title":"Global incidence and mortality of pancreatic diseases: a systematic review, meta-analysis, and meta-regression of population-based cohort studies","volume":"1","author":"Xiao","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.arteri.2025.500800_bib0160","first-page":"495","article-title":"Clinical practice guideline: acute and chronic pancreatitis","volume":"119","author":"Beyer","year":"2022","journal-title":"Deutsches \u00c4rzteblatt Int"},{"key":"10.1016\/j.arteri.2025.500800_bib0165","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.pan.2020.06.005","article-title":"Hypertriglyceridemia and acute pancreatitis","volume":"20","author":"Yang","year":"2020","journal-title":"Pancreatology"},{"key":"10.1016\/j.arteri.2025.500800_bib0170","doi-asserted-by":"crossref","first-page":"m3109","DOI":"10.1136\/bmj.m3109","article-title":"Management of hypertriglyceridemia","volume":"371","author":"Simha","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.arteri.2025.500800_bib0305","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4103\/ijem.ijem_206_22","article-title":"Hypertriglyceridemia-Induced Acute Pancreatitis - Course, Outcome, and Comparison with Non-Hypertriglyceridemia Associated Pancreatitis","volume":"26","author":"Shafiq","year":"2022","journal-title":"Indian J Endocrinol Metab."},{"key":"10.1016\/j.arteri.2025.500800_bib0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/4721357","article-title":"Management of hypertriglyceridemia induced acute pancreatitis","volume":"2018","author":"Garg","year":"2018","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.arteri.2025.500800_bib0185","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.pan.2020.03.018","article-title":"Hypertriglyceridemia-induced acute pancreatitis: a prospective, multicenter, international cohort analysis of 716 acute pancreatitis cases","volume":"20","author":"Mosztbacher","year":"2020","journal-title":"Pancreatology"},{"key":"10.1016\/j.arteri.2025.500800_bib0190","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11883-021-00962-z","article-title":"Clinical management of hypertriglyceridemia in the prevention of cardiovascular disease and pancreatitis","volume":"23","author":"Hernandez","year":"2021","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.arteri.2025.500800_bib0195","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41575-018-0087-5","article-title":"Global epidemiology and holistic prevention of pancreatitis","volume":"16","author":"Petrov","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.arteri.2025.500800_bib0200","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.2337\/dc17-0542","article-title":"Incidence demographics, and clinical characteristics of diabetes of the exocrine pancreas (type 3c): a retrospective cohort study","volume":"40","author":"Woodmansey","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.arteri.2025.500800_bib0205","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/jdi.14056","article-title":"Role of glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1 in hypertriglyceridemia and diabetes","volume":"14","author":"Kurooka","year":"2023","journal-title":"J Diabetes Invest"},{"key":"10.1016\/j.arteri.2025.500800_bib0210","first-page":"RA359","article-title":"Dietary fats, fatty acids and insulin resistance: short review of a multifaceted connection","volume":"11","author":"Haag","year":"2005","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.arteri.2025.500800_bib0215","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/SLA.0000000000002766","article-title":"Determinants of severity in acute pancreatitis","volume":"270","author":"Sternby","year":"2019","journal-title":"Ann Surg"},{"key":"10.1016\/j.arteri.2025.500800_bib0220","first-page":"825","article-title":"The diagnosis and treatment of hypertriglyceridemia","volume":"116","author":"Parhofer","year":"2019","journal-title":"Deutsches \u00c4rzteblatt Int"},{"key":"10.1016\/j.arteri.2025.500800_bib0225","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S1096-7192(03)00065-9","article-title":"Impact of the Pro12Ala polymorphism of the PPAR-\u03b32 gene on serum triacylglycerol response to n\u22123 fatty acid supplementation","volume":"79","author":"Lindi","year":"2003","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.arteri.2025.500800_bib0230","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.2337\/diabetes.51.7.2005","article-title":"Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha","volume":"51","author":"Itani","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.arteri.2025.500800_bib0235","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jacl.2022.08.001","article-title":"GPIHBP1 autoantibody is an independent risk factor for the recurrence of hypertriglyceridemia-induced acute pancreatitis","volume":"16","author":"Zhang","year":"2022","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.arteri.2025.500800_bib0240","doi-asserted-by":"crossref","first-page":"125","DOI":"10.5551\/jat.64112","article-title":"Efficacy and safety of pemafibrate, a novel selective PPAR\u03b1 modulator in chinese patients with dyslipidemia: a double-masked, randomized placebo- and active-controlled comparison trial","volume":"32","author":"Dai","year":"2025","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.arteri.2025.500800_bib0245","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3390\/diseases11040140","article-title":"Effectiveness and safety of fenofibrate in routine treatment of patients with hypertriglyceridemia and metabolic syndrome","volume":"11","author":"Ezhov","year":"2023","journal-title":"Diseases"},{"key":"10.1016\/j.arteri.2025.500800_bib0250","first-page":"525","article-title":"Management of dyslipidemias with fibrates, alone and in combination with statins: role of delayed-release fenofibric acid","volume":"6","author":"Moutzouri","year":"2010","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.arteri.2025.500800_bib0255","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/sj.ijo.0802613","article-title":"Isotretinoin and fenofibrate induce adiposity with distinct effect on metabolic profile in a rat model of the insulin resistance syndrome","volume":"28","author":"Sedova","year":"2004","journal-title":"Int J Obes"},{"key":"10.1016\/j.arteri.2025.500800_bib0260","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00041433-199904000-00009","article-title":"Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging","volume":"10","author":"Pineda Torra","year":"1999","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.arteri.2025.500800_bib0265","first-page":"422","volume":"7","year":"2018","journal-title":"Asia-Pac J Ophthalmol"},{"key":"10.1016\/j.arteri.2025.500800_bib0270","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s11892-016-0786-7","article-title":"Fenofibrate and diabetic retinopathy","volume":"16","author":"Knickelbein","year":"2016","journal-title":"Curr Diabetes Rep"},{"key":"10.1016\/j.arteri.2025.500800_bib0275","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10557-014-6534-9","article-title":"Lipid-lowering therapies, glucose control and incident diabetes: evidence mechanisms and clinical implications","volume":"28","author":"Zafrir","year":"2014","journal-title":"Cardiovasc Drugs Therapy"},{"key":"10.1016\/j.arteri.2025.500800_bib0280","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2165\/11207690-000000000-00000","article-title":"Fenofibrate: a review of its lipid-modifying effects in dyslipidemia and its vascular effects in type 2 diabetes mellitus","volume":"11","author":"Keating","year":"2011","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.arteri.2025.500800_bib0285","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1080\/07853890.2022.2090601","article-title":"Post-pancreatitis diabetes mellitus: insight on optimal management with nutrition and lifestyle approaches","volume":"54","author":"Singh","year":"2022","journal-title":"Ann Med"},{"key":"10.1016\/j.arteri.2025.500800_bib0290","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1038\/s41598-023-31947-4","article-title":"Machine learning for post-acute pancreatitis diabetes mellitus prediction and personalized treatment recommendations","volume":"13","author":"Zhang","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.arteri.2025.500800_bib0295","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1007\/s00330-019-06126-7","article-title":"Pancreas shrinkage following recurrent acute pancreatitis: an MRI study","volume":"29","author":"DeSouza","year":"2019","journal-title":"Eur Radiol"},{"key":"10.1016\/j.arteri.2025.500800_bib0300","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.dld.2024.10.009","article-title":"Clinical and imaging predictors for the development of diabetes mellitus following a single episode of acute pancreatitis in youth","volume":"57","author":"Ginzburg","year":"2025","journal-title":"Digest Liver Dis"}],"container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916825000439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916825000439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T07:35:31Z","timestamp":1767339331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0214916825000439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0214916825000439"],"URL":"https:\/\/doi.org\/10.1016\/j.arteri.2025.500800","relation":{},"ISSN":["0214-9168"],"issn-type":[{"type":"print","value":"0214-9168"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the link between fibrates therapy and diabetes mellitus following primary acute pancreatitis with hypertriglyceridemia","name":"articletitle","label":"Article Title"},{"value":"Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arteri.2025.500800","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Arteriosclerosis.","name":"copyright","label":"Copyright"}],"article-number":"500800"}}